Creutzfeldt-Jakob disease.
There has been significant advance in our understanding of CJD and similar spongiform encephalopathies in recent years. The range in clinical expression of the disease is better appreciated, and the existence of "atypical" cases of CJD is increasingly recognized. New ideas about the possible modes of natural transmission have been derived from case-control studies in different parts of the world.
D000818:Animals; D001706:Biopsy; D001921:Brain / Q000473:pathology; D007562:Creutzfeldt-Jakob Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D004569:Electroencephalography; D006041:Goats; D000882:Haplorhini; D006801:Humans; D007557:Israel; D007773:Lactates / Q000134:cerebrospinal fluid; D019344:Lactic Acid; D008002:Libya / Q000208:ethnology; D008460:Meat / Q000009:adverse effects; D051379:Mice; D009207:Myoclonus / Q000209:etiology; D009454:Neurofibrils / Q000473:pathology; D012608:Scrapie / Q000635:transmission; D012756:Sheep; D012897:Slow Virus Diseases / Q000635:transmission; D014065:Tonometry, Ocular / Q000009:adverse effects
D007773:Lactates; D019344:Lactic Acid